+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Advanced Wound Care Market Report and Forecast 2023-2031

  • PDF Icon


  • 147 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797851
The advanced wound care market size attained a value of USD 9.4 billion in 2022. The market is anticipated to grow at a CAGR of 6.90% during the forecast period of 2023-2031, likely to attain a value of USD 17.2 billion by 2031.

Advanced Wound Care: Introduction

Advanced wound care refers to a range of therapies and treatments that are used to promote the healing of complex, chronic, or difficult-to-heal wounds. These types of wounds may include diabetic ulcers, pressure ulcers, surgical wounds, and traumatic injuries, among others.

Advanced wound care products and therapies are designed to accelerate the healing process by promoting the growth of new tissue, reducing inflammation, and preventing infection. These products may include specialized dressings, wound fillers, skin substitutes, growth factors, and negative pressure wound therapy.

One of the key advantages of advanced wound care is that it can help to reduce the risk of complications and improve patient outcomes. For example, advanced wound care products may help to prevent the formation of scar tissue, reduce pain, discomfort, and improve mobility.

The market for advanced wound care products and therapies has been growing in recent years, driven by factors such as the increasing prevalence of chronic diseases, aging populations, and rising healthcare costs. Some of the key players in the market include 3M Health Care, Acelity L.P. Inc., ConvaTec Inc., and Smith & Nephew plc.

Overall, advanced wound care is an important area of healthcare that can help to improve patient outcomes and reduce the burden of chronic wounds on healthcare systems. As research and development continue to advance, the market for advanced wound care is expected to continue growing in the coming years.

Advanced Wound Care Market Segmentations

The market can be categorised into product type, wound class, wound type, end user, distribution channel, and region.

Market by Product Type

  • Wound Dressing
  • Moist Wound Care
  • Foam Dressing
  • Hydrocolloid Dressing
  • Film Dressing
  • Alginate Dressing
  • Hydrogel Dressing
  • Collagen Dressing
  • Other Advanced Dressing
  • Antimicrobial Wound Care
  • Silver
  • Non-silver
  • Active Wound Care
  • Biomaterials
  • Skin-substitute
  • Wound Therapy Devices
  • Negative Pressure Wound Therapy
  • Oxygen And Hyperbaric Oxygen Equipment
  • Electric Stimulation Devices
  • Pressure Relief Devices
  • Others

Market Breakup by Wound Class

  • Class I
  • Class II
  • Class III
  • Class IV

Market Breakup by Wound Type

  • Primary Wound Care
  • Secondary Wound Care

Market Breakup by End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Homecare Settings
  • Others

Market Breakup by Distribution Channel

  • Direct Tenders
  • Retail Stores
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Advanced Wound Care Market Scenario

The advanced wound care market has experienced significant growth in recent years, driven by various factors such as an aging global population, increased prevalence of chronic diseases, and technological advancements. The rising incidence of diabetes and obesity has led to an increase in hard-to-heal wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, propelling the demand for advanced wound care products.

Additionally, the growing awareness of the benefits of advanced wound care, coupled with increased healthcare spending and investments in research and development, has spurred the market growth. Technological innovations, including the use of nanotechnology, stem cells, and 3D printing, have further expanded the range of available wound care solutions, enabling more effective and personalized treatment options. Lastly, strategic partnerships and acquisitions among key industry players have bolstered the market's competitive landscape, driving the development of new products and expanding the global reach.

Key Players in the Global Advanced Wound Care Market

The report gives an in-depth analysis of the key players involved in the advanced wound care market. The companies included in the market are as follows:
  • 3M
  • Smith & Nephew plc
  • Integra LifeSciences Holdings Corporation
  • Mölnlycke Health Care AB
  • ConvaTec Group plc
  • Coloplast A/S
  • Medline Industries, Inc
  • Advanced Medical Solutions Group plc
  • Hollister Incorporated
  • B. Braun Melsungen AG
  • DeRoyal Industries, Inc
  • Advancis Medical
  • Cardinal Health
  • DermaRite Industries, LLC
  • Urgo Medical
  • Shield Line
  • Winner Medical Co., Ltd
  • Zhejiang Top-Medical Medical Dressing Co., Ltd
  • North Coast Medical

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Advanced Wound Care Market Overview
3.1 Global Advanced Wound Care Market Historical Value (2016-2022)
3.2 Global Advanced Wound Care Market Forecast Value (2023-2031)
4 Global Advanced Wound Care Market Landscape
4.1 Global Advanced Wound Care Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Advanced Wound Care Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by End User
4.2.3 Analysis by Distribution Channel
5 Global Advanced Wound Care Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Advanced Wound Care Market Segmentation
6.1 Global Advanced Wound Care Market by Product Type
6.1.1 Wound Dressing Foam Dressing Hydrocolloid Dressing Film Dressing Alginate Dressing Hydrogel Dressing Collagen Dressing Other Advanced Dressing
6.1.2 Active Wound Care Biomaterials Skin-substitute Others
6.1.3 Wound Care Devices Negative Pressure Wound Therapy (NPWT) Oxygen And Hyperbaric Oxygen Equipment Electric Stimulation Devices Pressure Relief Devices Others
6.2 Global Advanced Wound Care Market by Wound Type
6.2.1 Market Overview
6.2.2 Chronic Wounds Pressure Ulcers Diabetic Foot Ulcers Arterial and Venous Ulcers Others
6.2.3 Acute Wounds Burns and Trauma Surgical Wounds
6.3 Global Advanced Wound Care Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Ambulatory Surgical Centres
6.3.5 Homecare Settings
6.3.6 Others
6.4 Global Advanced Wound Care Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Advanced Wound Care Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Advanced Wound Care Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Advanced Wound Care Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Advanced Wound Care Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Advanced Wound Care Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 3M
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Smith & Nephew plc
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Integra LifeSciences Holdings Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Mölnlycke Health Care AB
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 ConvaTec Group plc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Coloplast A/S
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medline Industries, Inc
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Advanced Medical Solutions Group plc
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Hollister Incorporated
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 B. Braun Melsungen AG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 DeRoyal Industries, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Zimmer Biomet
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Cardinal Health
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 DermaRite Industries, LLC
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Shield Line
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
18 Global Advanced Wound Care Market-Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • 3M
  • Smith & Nephew plc
  • Integra Lifesciences Holdings Corporation
  • Mölnlycke Health Care Ab
  • Convatec Group plc.
  • Coloplast A/S
  • Medline Industries, Inc
  • Advanced Medical Solutions Group plc
  • Hollister Incorporated
  • B. Braun Melsungen AG
  • Deroyal Industries, Inc.
  • Paul Hartmann AG
  • Zimmer Biomet
  • Cardinal Health
  • Dermarite Industries, LLC
  • Shield Line



Table Information